At its meeting on November 17, 2020, the Board approved $34 million to fund seven comparative clinical effectiveness research (CER) studies designed to improve care for health conditions that impose high burdens on patients, their families and the health care system.
Among the newly funded studies are an Alabama-based study to compare the effectiveness of treatment strategies for people with rheumatoid arthritis, a Pennsylvania-based tudy comparing a psychological intervention, drug treatment and the combination of these two strategies for treating post-traumatic stress disorder, and a Washington state-based study that will be the first national randomized trial on improving outcomes for African-American women with endometrial cancer.
View this news release to learn more about each of the approved studies.
During the meeting, PCORI Executive Director Nakela Cook, MD, MPH, also presented a Strategic Planning Committee update and preview, and outlined the Diversity, Equity, Inclusion (DEI) framework.
- Board of Governors
- Governance Committees
- Broad PCORI Funding Announcements -- Cycle 1 2020
- Improving Methods for Conducting Patient-Centered Outcomes Research -- Cycle 1 2020
All PCORI Board meetings are open to the public. This meeting was held via teleconference/webinar with no public comment period.
Catch up on past PCORI Board meetings here.